National Institute On Deafness and Other Communication Disorders; Notice of Closed Meetings, 57570-57571 [2012-22926]
Download as PDF
<![CDATA[
57570
Federal Register / Vol. 77, No. 181 / Tuesday, September 18, 2012 / Notices
I. CBER Advisory Committee
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–N–0001]
Request for Notification From Industry
Organizations Interested in
Participating in the Selection Process
for Nonvoting Industry Representative
on the Transmissible Spongiform
Encephalopathies Advisory
Committee, and Request for
Nominations for Nonvoting Industry
Representatives on the Transmissible
Spongiform Encephalopathies
Advisory Committee
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is requesting that
any industry organizations interested in
participating in the selection of a
nonvoting industry representative to
serve on the Transmissible Spongiform
Encephalopathies Advisory Committee
for the Center for Biologics Evaluation
and Research (CBER) notify FDA in
writing. FDA is also requesting
nominations for a nonvoting industry
representative to serve on the
Transmissible Spongiform
Encephalopathies Advisory Committee.
A nominee may either be selfnominated or nominated by an
organization to serve as a nonvoting
industry representative. Nominations
will be accepted for current vacancies
effective with this notice.
DATES: Any industry organization
interested in participating in the
selection of an appropriate nonvoting
member to represent industry interests
must send a letter stating that interest to
FDA by October 18, 2012, for the
vacancy listed in this notice.
Concurrently, nomination materials for
prospective candidates should be sent to
FDA by October 18, 2012.
ADDRESSES: All letters of interest and
nominations should be submitted in
writing to Bryan Emery (see: FOR
FURTHER INFORMATION CONTACT).
FOR FURTHER INFORMATION CONTACT:
Bryan Emery, Center for Biologics
Evaluation and Research, Food and
Drug Administration, 1401 Rockville
Pike (HFM–71), Rockville, MD 20852–
1448, 301–827–1277, FAX: 301–827–
0294, bryan.emery@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: The
Agency intends to add a nonvoting
industry representative to the following
advisory committee:
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
18:39 Sep 17, 2012
Jkt 226001
Transmissible Spongiform
Encephalopathies Advisory Committee
Members are selected by the
Commissioner of Food and Drugs (the
Commissioner) or designee from among
authorities knowledgeable in the fields
of clinical and administrative medicine,
hematology, virology, neurovirology,
neurology, infectious diseases,
immunology, transfusion medicine,
surgery, internal medicine,
biochemistry, biostatistics,
epidemiology, biological and physical
sciences, sociology/ethics, and other
related professions.
II. Selection Procedure
Any industry organization interested
in participating in the selection of an
appropriate nonvoting member to
represent industry interests should send
a letter stating that interest to the FDA
contact (see FOR FURTHER INFORMATION
CONTACT) within 30 days of publication
of this document (see DATES). Within the
subsequent 30 days, FDA will send a
letter to each organization that has
expressed an interest, attaching a
complete list of all such organizations;
and a list of all nominees along with
´
´
their current resumes. The letter will
also state that it is the responsibility of
the interested organizations to confer
with one another and to select a
candidate, within 60 days after the
receipt of the FDA letter, to serve as the
nonvoting member to represent industry
interests for the committee. The
interested organizations are not bound
by the list of nominees in selecting a
candidate. However, if no individual is
selected within 60 days, the
Commissioner will select the nonvoting
member to represent industry interests.
III. Application Procedure
Individuals may self nominate and/or
an organization may nominate one or
more individuals to serve as a nonvoting
industry representative. Contact
information, a current curriculum vitae,
and the name of the committee of
interest should be sent to the FDA
contact person (see FOR FURTHER
INFORMATION CONTACT) within 30 days of
publication of this document (see
DATES). FDA will forward all
nominations to the organizations
expressing interest in participating in
the selection process for the committee.
(Persons who nominate themselves as
nonvoting industry representatives will
not participate in the selection process).
FDA seeks to include the views of
women and men, members of all racial
and ethnic groups, and individuals with
and without disabilities on its advisory
PO 00000
Frm 00015
Fmt 4703
Sfmt 4703
committees and, therefore encourages
nominations of appropriately qualified
candidates from these groups.
Specifically, in this document,
nominations for nonvoting
representatives of industry interests are
encouraged from the blood,
epidemiology, and neurovirology
manufacturing industry.
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14,
relating to advisory committees.
Dated: September 12, 2012.
Jill Hartzler Warner,
Acting Associate Commissioner for Special
Medical Programs.
[FR Doc. 2012–22866 Filed 9–17–12; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute On Deafness and
Other Communication Disorders;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Communication
Disorders Review Committee.
Date: October 18–19, 2012
Time: October 18, 2012, 8:00 a.m. to 5:00
p.m.
Agenda: To review and evaluate grant
applications.
Place: Wyndham Riverfront New Orleans,
701 Convention Center Blvd., New Orleans,
LA.
Time: October 19, 2012, 8:00 a.m. to 5:00
p.m.
Agenda: To review and evaluate grant
applications.
Place: Wyndham Riverfront New Orleans,
701 Convention Center Blvd., New Orleans,
LA.
Contact Person: Susan Sullivan, Ph.D.,
Scientific Review Branch, Division of
Extramural Activities, NIDCD, NIH, 6120
Executive Blvd., Suite 400C, Bethesda, MD
20892, 301–496–8683, sullivas@mail.nih.gov.
Name of Committee: National Institute on
Deafness and Other Communication
E:\FR\FM\18SEN1.SGM
18SEN1
Federal Register / Vol. 77, No. 181 / Tuesday, September 18, 2012 / Notices
Disorders Special Emphasis Panel; Hearing
and Balance Fellowships.
Date: October 26, 2012.
Time: 11:30 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6120
Executive Blvd., Rockville, MD 20852,
(Telephone Conference Call).
Contact Person: Sheo Singh, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Activities,
Executive Plaza South, Room 400C, 6120
Executive Blvd., Bethesda, MD 20892, 301–
496–8683, singhs@nidcd.nih.gov.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; NIDCD
Small Business (SBIR/STTR) Applications
Review Meeting.
Date: October 30, 2012.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6120
Executive Blvd., Rockville, MD 20852.
Contact Person: Kausik Ray, Ph.D.,
Scientific Review Officer, National Institute
on Deafness and Other Communication
Disorders, National Institutes of Health,
Rockville, MD 20850, 301–402–3587,
rayk@nidcd.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health, HHS)
Dated: September 11, 2012.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–22926 Filed 9–17–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSK4VPTVN1PROD with NOTICES
Center For Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Program
Project: DNA Replication, Repair,
Recombination, Disease and Mutation.
VerDate Mar<15>2010
18:39 Sep 17, 2012
Jkt 226001
Date: October 15, 2012.
Time: 3:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: David J Remondini, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2210,
MSC 7890, Bethesda, MD 20892, 301–435–
1038, remondid@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel R15:
Dermatology, Rheumatology, Dental, Bone,
Muscle and Biomaterial Sciences.
Date: October 17–18, 2012.
Time: 7:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Aruna K Behera, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4211,
MSC 7814, Bethesda, MD 20892, 301–435–
6809, beheraak@csr.nih.gov.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group;
Integrative Physiology of Obesity and
Diabetes Study Section.
Date: October 18–19, 2012.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Allerton Hotel, 701 North
Michigan Avenue, Chicago, IL 60611.
Contact Person: Reed A Graves, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6166,
MSC 7892, Bethesda, MD 20892, (301) 402–
6297, gravesr@csr.nih.gov.
Name of Committee: Cardiovascular and
Respiratory Sciences Integrated Review
Group; Myocardial Ischemia and Metabolism
Study Section.
Date: October 18, 2012.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Kimm Hamann, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118A,
MSC 7814, Bethesda, MD 20892, 301–435–
5575, hamannkj@csr.nih.gov.
Name of Committee: Genes, Genomes, and
Genetics Integrated Review Group;
Genomics, Computational Biology and
Technology Study Section.
Date: October 18–19, 2012.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Washington DC,
Dupont Circle, 1143 New Hampshire Avenue
NW., Washington, DC 20037.
PO 00000
Frm 00016
Fmt 4703
Sfmt 4703
57571
Contact Person: Barbara J Thomas, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2218,
MSC 7890, Bethesda, MD 20892, 301–435–
0603, bthomas@csr.nih.gov.
Name of Committee: Cardiovascular and
Respiratory Sciences Integrated Review
Group; Cardiac Contractility, Hypertrophy,
and Failure Study Section.
Date: October 18, 2012.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Washington DC,
Dupont Circle, 1143 New Hampshire Avenue
NW., Washington, DC 20037.
Contact Person: Olga A Tjurmina, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4030B,
MSC 7814, Bethesda, MD 20892, (301) 451–
1375, ot3d@nih.gov.
Name of Committee: Cardiovascular and
Respiratory Sciences Integrated Review
Group; Clinical and Integrative
Cardiovascular Sciences Study Section.
Date: October 18–19, 2012.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Courtyard by Marriott, 5520
Wisconsin Avenue, Chevy Chase, MD 20815.
Contact Person: Delvin R Knight, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive Room 6194
MSC 4128, Bethesda, MD 20892–7814, 301–
435–1850, knightdr@csr.nih.gov.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group; Cellular,
Molecular and Integrative Reproduction
Study Section.
Date: October 18, 2012.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sheraton Delfina Santa Monica
Hotel 530 West Pico Boulevard, Santa
Monica, CA 90405.
Contact Person: Gary Hunnicutt, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6164,
MSC 7892, Bethesda, MD 20892, 301–435–
0229, gary.hunnicutt@nih.gov.
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group; Child Psychopathology and
Developmental Disabilities Study Section.
Date: October 18–19, 2012.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Courtyard Chicago Downtown/River
North, 30 East Hubbard, Chicago, IL 60611.
Contact Person: Jane A DoussardRoosevelt, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 3184, MSC 7848, Bethesda, MD 20892,
(301) 435–4445, doussarj@csr.nih.gov.
Name of Committee: Immunology
Integrated Review Group; Cellular and
Molecular Immunology—B Study Section.
E:\FR\FM\18SEN1.SGM
18SEN1
]]>Agencies
[Federal Register Volume 77, Number 181 (Tuesday, September 18, 2012)]
[Notices]
[Pages 57570-57571]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-22926]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute On Deafness and Other Communication Disorders;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Communication Disorders Review Committee.
Date: October 18-19, 2012
Time: October 18, 2012, 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Wyndham Riverfront New Orleans, 701 Convention Center
Blvd., New Orleans, LA.
Time: October 19, 2012, 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Wyndham Riverfront New Orleans, 701 Convention Center
Blvd., New Orleans, LA.
Contact Person: Susan Sullivan, Ph.D., Scientific Review Branch,
Division of Extramural Activities, NIDCD, NIH, 6120 Executive Blvd.,
Suite 400C, Bethesda, MD 20892, 301-496-8683, sullivas@mail.nih.gov.
Name of Committee: National Institute on Deafness and Other
Communication
[[Page 57571]]
Disorders Special Emphasis Panel; Hearing and Balance Fellowships.
Date: October 26, 2012.
Time: 11:30 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6120 Executive Blvd.,
Rockville, MD 20852, (Telephone Conference Call).
Contact Person: Sheo Singh, Ph.D., Scientific Review Officer,
Scientific Review Branch, Division of Extramural Activities,
Executive Plaza South, Room 400C, 6120 Executive Blvd., Bethesda, MD
20892, 301-496-8683, singhs@nidcd.nih.gov.
Name of Committee: National Institute on Deafness and Other
Communication Disorders Special Emphasis Panel; NIDCD Small Business
(SBIR/STTR) Applications Review Meeting.
Date: October 30, 2012.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6120 Executive Blvd.,
Rockville, MD 20852.
Contact Person: Kausik Ray, Ph.D., Scientific Review Officer,
National Institute on Deafness and Other Communication Disorders,
National Institutes of Health, Rockville, MD 20850, 301-402-3587,
rayk@nidcd.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.173,
Biological Research Related to Deafness and Communicative Disorders,
National Institutes of Health, HHS)
Dated: September 11, 2012.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-22926 Filed 9-17-12; 8:45 am]
BILLING CODE 4140-01-P
